1. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes. Issue 8 (November 2014) Authors: Aubert, C.E.; Michel, P.‐L.; Gillery, P.; Jaisson, S.; Fonfrede, M.; Morel, F.; Hartemann, A.; Bourron, O. Journal: Diabetes/metabolism research and reviews Issue: Volume 30:Issue 8(2014:Nov.) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparability study of candidate reference methods for LDL-P measurements. (September 2016) Authors: Clouet Foraison, N.; Vaslin-Reimann, S.; Cobbaert, C.; Gillery, P.; Delatour, V. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of elastin-derived peptides (EDPS) and carbamylated-EDPS on vascular smooth muscle cells phenotype in relation to atherosclerosis development. (August 2021) Authors: Henry, A.; Berquand, A.; Terryn, C.; Maurice, P.; Bennasroune, A.; Blaise, S.; Romier-Crouzet, B.; Sartelet, H.; Gillery, P.; Jaisson, S.; Duca, L. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IDF21-0047 Association between the advanced glycation end-products and the vascular complications in T1D – The DIABAGE study. (April 2022) Authors: Diallo, A.M.; Jaisson, S.; Barriquand, R.; Lukas, C.; Barraud, S.; Decoudier, B.; Francois, M.; Ly, S.; Arndt, C.; Nazeyrollas, P.; Gillery, P.; Delemer, B. Journal: Diabetes research and clinical practice Issue: Volume 186:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗